Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 5, 2013
Evidence-based approach to harmonised reference intervals
Gus Koerbin, Ken Andrew Sikaris, Graham Ross Dallas Jones, et al.
Annals of Clinical Biochemistry
|
April 26, 2007
Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease
Peter E Hickman, Gus Koerbin, Emma Southcott, et al.
British Journal of Haematology
|
March 7, 2012
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis
Peter Mollee, Campbell Tiley, Ilona Cunningham, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 16, 2014
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity
Kevin J Fagan, Carel J Pretorius, Leigh U Horsfall, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 5, 2013
Evidence-based approach to harmonised reference intervals
Gus Koerbin, Ken Andrew Sikaris, Graham Ross Dallas Jones, et al.
Annals of Clinical Biochemistry
|
April 26, 2007
Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease
Peter E Hickman, Gus Koerbin, Emma Southcott, et al.
British Journal of Haematology
|
March 7, 2012
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis
Peter Mollee, Campbell Tiley, Ilona Cunningham, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 16, 2014
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity
Kevin J Fagan, Carel J Pretorius, Leigh U Horsfall, et al.
Page
of 3